Berkeley, CA, United States of America

Daniel E Lopes De Menezes

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel E Lopes De Menezes

Introduction

Daniel E Lopes De Menezes is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of medical therapies, particularly in cancer treatment. His innovative approach combines specific antibodies to enhance therapeutic efficacy.

Latest Patents

One of his key patents is titled "Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody." This patent provides a novel combination therapy for treating subjects afflicted with lung cancer. The therapy involves administering both an anti-fucosyl-GM1 antibody and an anti-CD137 antibody, or antigen-binding portions of either or both.

Career Highlights

Daniel is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His work focuses on developing advanced therapies that target complex diseases, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues, including Josephine M Cardarelli and Paul D Ponath. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Daniel E Lopes De Menezes exemplifies the spirit of innovation in the medical field. His contributions, particularly in cancer therapy, highlight the importance of combining scientific knowledge with practical applications. His work continues to inspire advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…